Clinical trial · Interventional
Cognitive Support Program for Patients With Brain Metastases
NCT03537911CI-TRIAL-00038171completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study evaluates the feasibility and preliminary efficacy of a brief cognitive-behavioural program designed to improve cognitive functioning in people with brain metastases.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Metastases, CNS | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Cognitive Support Program | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Cognitive Support Program
- description
- Three individual sessions of supportive psychoeducation, mindfulness practice, and strategy training (e.g., strategies to improve memory or concentration), with practice applying program content between sessions.
- interventionNames
- Behavioral: Cognitive Support Program
Primary outcomes (1)
- measure
- Functional Assessment of Cancer Therapy - Cognitive
- timeFrame
- Baseline; 2 months (0-2 weeks post-training); 5 months (3 months post-training)
- description
- Multi-domain cognitive symptom questionnaire completed at each time point. Raw scores are converted to z-scores (M = 0, SD = 1, higher scores = better functioning) according to published criteria, and change from baseline to post-training and to 3-month follow-up calculated by subtraction.
Secondary outcomes (10)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * age 18 or older * able to provide informed consent to all procedures * diagnosis of one or more brain metastases, with primary cancer outside the CNS * indication of cognitive deficits from self-report and/or cognitive testing * interest in participating in a cognitive rehabilitation program * able to complete study activities Exclusion Criteria: * concurrent non-cancer-related neurological or major psychiatric disorder or other medical condition suspected to influence cognition
References
Publications (0)
Data not yet available
No reference posted for this study.